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Octogenarians with contralateral carotid artery
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endarterectomy?
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Oreste Terranova, MD,b and Claudio Baracchini, MD,c Padua, Italy
Purpose: Carotid angioplasty and stenting has been proposed as a treatment option for carotid occlusive disease in patients
at high risk, including those 80 years of age or older or with contralateral carotid occlusion. We analyzed 30-day mortality
and stroke risk rates of carotid endarterectomy (CEA) in patients aged 80 years or older with concurrent carotid occlusive
disease.
Methods: From a retrospective review of 1000 patients undergoing 1150 CEA procedures to treat symptomatic and
asymptomatic carotid lesions over 13 years, we identified 54 patients (5.4%) aged 80 years or older with concurrent
contralateral carotid occlusion. These patients were compared with 38 patients (3.8%) aged 80 years or older with normal
or diseased patent contralateral carotid artery and 81 patients (8.1%) younger than 80 years with contralateral carotid
occlusion. All CEA procedures involved either standard CEA with patching or eversion CEA, and were performed by the
same surgeon, with the patients under deep general anesthesia and cerebral protection involving continuous perioperative
electroencephalographic monitoring for selective shunting. Shunting criteria were based exclusively on electroencepha-
lographic abnormalities consistent with cerebral ischemia.
Results: The 30-day mortality and stroke rate in patients aged 80 years or older with concurrent contralateral carotid
occlusion was zero.
Conclusions. The concept of high-risk CEA needs to be revisited. Patients with two of the criteria considered high risk in
the medical literature, that is, age 80 years or older and contralateral carotid occlusion, can undergo CEA with no greater
risks or complications. Until prospective randomized trials designed to evaluate the role of carotid angioplasty and
stenting have been completed, CEA should remain the standard treatment in such patients. (J Vasc Surg 2004;39:
1003-8.)Carotid endarterectomy (CEA) is currently considered
the most effective treatment for stroke prevention in pa-
tients with high-grade symptomatic or asymptomatic inter-
nal carotid artery (ICA) disease.1-3 For CEA to be worth-
while, however, the long-term benefit (stroke prevention)
must outweigh the perioperative risk (death and stroke).4
In recent years carotid angioplasty and stenting (CAS) has
emerged as a safe and potentially less invasive alternative to
CEA.5-11 Although no prospective randomized controlled
studies with a power sufficient to determine any significant
differences between CEA and CAS in typical patient evalu-
ation have been completed as yet,12,13 considerable expe-
rience with CAS has been collected worldwide. Recently
published consensus statements have suggested, however,
that CAS should be performed in a restricted patient pop-
ulation, defined as “high risk” or “unfit for surgery,” gen-
erally including patients with recurrent ICA stenosis, pre-
vious neck irradiation, anatomically unsuitable lesions,
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doi:10.1016/j.jvs.2004.01.029severe medical comorbid conditions, and contralateral ca-
rotid occlusion.14,15 Proponents of CAS have also included
patients ineligible for multicenter symptomatic and asymp-
tomatic trials, such as patients aged 80 years or older.5-7
Because the definition of high risk or unfit for surgery has
not been established, it varies considerably between advo-
cates of surgical versus endovascular treatment of carotid
lesions. Many authors have challenged the concept of high-
risk CEA, demonstrating that the surgical procedure can be
safe, effective, and durable even in patients assumed to be at
greater risk, which would account for 20% to 30% of
patients seen in contemporary carotid practice.16-20
In an effort to stratify CEA risk, we evaluated the
perioperative (30-day) outcome of CEA in a cohort of
patients with two of the criteria considered high risk in the
literature, that is, age 80 years or older and contralateral
carotid occlusion. We then compared these results with
findings for CEA performed in patients 80 years or older
with patent contralateral ICAs and in patients younger than
80 years with contralateral carotid occlusion.
PATIENTS AND METHODS
Records were reviewed for all patients with symptom-
atic and asymptomatic high-grade ICA lesions, according
to the recommendations of the North American Symptom-
atic Carotid Endarterectomy Trial (NASCET)1 and the
Asymptomatic Carotid Atherosclerosis Study (ACAS),3
who underwent primary CEA at our institution between1003
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spectively collected in a computerized database. Patients
scheduled for CEA with concomitant coronary artery by-
pass grafting and patients with associated supra-aortic trunk
lesions requiring concurrent surgery were excluded from
the analysis. Patient demographic data, including history of
diabetes mellitus, cigarette smoking, hypertension and cor-
onary artery disease, other clinical variables, indications for
surgery, details of the operation, and hospital stay, were
identified.
The diagnosis of an ICA lesion was made on the basis of
preoperative traditional angiography during the earlier part
of this experience (used with decreasing frequency over the
years), and duplex ultrasound scanning was the only pre-
operative ICA imaging study performed in most patients
from mid-1998 and after, combined with either magnetic
resonance (MR) angiography, computed tomography
(CT) angiography, or traditional arteriography in selected
patients. To differentiate preocclusive stenosis from occlu-
sion, we tried to detect extremely low flow velocity by
adjusting the color scale to low flow values or by using the
power Doppler scanning mode, or by administering echo
contrast agents. Only if the diagnosis was still unclear and in
case of complex sonographic conditions did we perform an
angiographic study. In addition, optimal instrument set-
tings and complete study of the vertebrobasilar system and
of the intracranial arteries with transcranial Doppler ultra-
sound scanning in all patients preoperatively helped in
reducing the risk for overestimating ICA stenosis because
of compensatory hyperperfusion secondary to contralateral
carotid occlusion. The radiologist’s estimate of carotid bulb
or ICA stenosis from the final angiography report was
recorded with the NASCET method.1 If arteriography was
not performed, stenosis was estimated on the strength of
findings of preoperative duplex ultrasound scanning per-
formed in our vascular laboratory.
Clinical presentation was always classified by the con-
sultant neurologist, as transient ischemic attack (TIA; tem-
porary hemispheric symptoms lasting no more than 24
hours, with complete recovery), amaurosis fugax (transient
monocular visual loss), or stroke (neurologic deficit persist-
ing for more than 24 hours, regardless of the mechanism,
and related to either cerebral hemisphere). Patients with
nonhemispheric symptoms, such as dizzy spells or vertigo,
were included in the asymptomatic group. Preoperative
cerebral CT was performed in all patients with symptoms.
Preoperative patient preparation was standardized. Anti-
platelet therapy (aspirin or dipyridamole, and ticlopidine or
clopidogrel in the final period) was suspended at least 1
week before the operation, and was not resumed until the
patient was discharged from the hospital.
All CEA procedures involved either traditional CEA,
with routine polytetrafluoroethylene patch angioplasty, or
eversion CEA. The technical details of both procedures are
described elsewhere.21,22 All CEA procedures were per-
formed by a single surgeon (E.B.), with the patients under
deep general anesthesia and cerebral protection involving
continuous perioperative electroencephalographic (EEG)monitoring for selective shunting. All perioperative EEGs
were visually analyzed by a neurologist with extensive ex-
perience in the interpretation of studies during sleep, either
natural or induced with hypnotic or anesthetic agents.
Shunting criteria were based exclusively on EEG changes
consistent with cerebral ischemia. Completion imaging
studies were never performed. Patients were usually moni-
tored in the recovery room for 2 hours before being trans-
ferred to a regular nursing unit specializing in vascular care,
and were monitored for 12 to 24 hours after surgery. Most
patients were discharged 48 to 72 hours after surgery.
The end points of the present study were perioperative
(30-day) stroke and death, and cardiac complications,
which were prospectively recorded according to the guide-
lines of the Ad Hoc Committee on Reporting Standards for
Cerebrovascular Disease, Society for Vascular Surgery,
North American Chapter of the International Society for
Cardiovascular Surgery.23 All patients were evaluated by a
consultant neurologist postoperatively. Minor stroke was
defined as minimal and stabilized focal neurologic deficit of
acute onset and persisting for more than 24 hours but not
leading to handicap or significant impairment in activities
of daily living. Major stroke was defined as deficit that lasted
more than 30 days and resulted in change in lifestyle. For
the purpose of this study, TIA and other neurologic deficits
lasting less than 24 hours, cervical and cranial nerve injury,
and neck hematomas were also stratified as secondary end
points. Cerebral CT or MR imaging was performed in all
patients with a new neurologic deficit after CEA.
Statistical analysis. All statistical analyses were per-
formed with the SPSS 10.0 statistical software package
(SPSS, Chicago, Ill). All values are expressed as mean SD.
Univariate analysis was performed on all clinical, morpho-
logic, and procedural variables, with the Student t test
(two-tailed) for continuous variables, and 2 analysis or the
Fisher exact test (two-tailed), as appropriate, for categorical
variables. Significance was assumed at P  .05.
RESULTS
Overall, 1000 patients underwent 1150 CEA proce-
dures. The perioperative mortality rate was 0.3% (3 of 1000
patients), and stroke rate was 0.9% (11 of 1150 patients),
with a combined mortality and stroke rate of 1.2%.
Among patients aged 80 years or older (n  92, 9.2%)
and those with contralateral carotid occlusion (n  135,
13.5%), we identified three subgroups for comparative
analysis: patients 80 years or older with contralateral carotid
occlusion (n  54, 5.4%; group 1), patients 80 years or
older with a normal or diseased patent contralateral ICA (n
 38, 3.8%; group 2), and patients younger than 80 years
with contralateral carotid occlusion (n  81, 8.1%; group
3). For the purpose of this analysis, groups 2 and 3 served as
comparison groups.
Preoperative demographic data for the groups consid-
ered are shown in Table I. The mean age in group 1 was
83.4 years (range, 80-92 years). Symptomatic lesions were
more frequent in group 1 than in group 2 (75.9% vs 52.6%;
P .02). The incidence of male gender (53.7% vs 79%; P
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history of smoking (24.1% vs 61.7%; P  .001) was statis-
tically lower in group 1 than in group 3. There was no
statistically significant difference in arterial hypertension,
coronary artery disease, congestive heart failure, history of
myocardial infarction, or renal failure. There was a statisti-
cally higher rate of peroperative EEG abnormalities sugges-
tive of cerebral ischemia requiring shunting in group 1
(79.6% vs 18.4%; P  .001), and shunting was required
statistically more often in group 1 than in group 2 (55.5% vs
15.7%; P  .001; Table II). Actual shunt usage was statis-
tically less frequent, however, than such EEG changes, in
both group 1 (79.6% vs 55.5%; P .04) and group 3 (79%
vs 53.1%; P  .02). Although the type of CEA (traditional
with patching or eversion) was similar in the three groups,
eversion CEA was performed more frequently, both in the
series as a whole (61.8% vs 38.2%; P  .001) and in each
group (group 1, 61.1% vs 38.9, P .03; group 2, 63.2% vs
36.8%, P .03; group 3, 61.7% vs 38.3%, P .001; Table
II).
Perioperative mortality and stroke rates. Overall,
the perioperative mortality rate was 0.5% (1 in 173 patients;
Table I. Demographic and clinical data
Factor
Group 1 (N  54)
n %
Age (y)
Mean 83.4 8
Range 80-92 8
Symptomatic disease 41 75.9 2
Male gender 29 53.7 1
Hypertension 38 70.4 2
Diabetes 10 18.5
CAD 25 46.3 1
CHF 7 12.9
MI 19 35.8 1
Smoking 13 24.1
Renal failure 4 7.4
CAD, Coronary artery disease; CHF, congestive heart failure; MI, myocard
Table II. Preoperative and perioperative anatomic and tec
Group 1 (N  54)
n %
Degree of contralateral
ICA lesion (%)
60
60-69
70-99
Occlusion 54
EEG changes 43 79.6
Shunt used 30 55.5
Patching 21 38.9*
Eversion 33 61.1*
ICA, Internal carotid artery; EEG, electroencephalographic; NS, not signifi
*P  .03, Fisher exact test.
†P  .03, Fisher exact test.
‡P  .001, Fisher exact test.Table III). The only perioperative death was stroke-related,
and occurred in a 71-year old man who underwent surgery
to treat a symptomatic left ICA lesion with contralateral
carotid occlusion. He awoke from the anesthesia with no
neurologic symptoms, but subsequently experienced pro-
gressive right hemiparesis, and died on postoperative day
10 of recurrent progressive stroke. The perioperative mor-
tality rate did not differ statistically between the groups.
Overall, there were two (1.1%) perioperative strokes, both
in group 3, but the perioperative stroke incidence was
statistically no different between the three groups. Whereas
the first stroke was major and fatal, the second stroke was
minor and occurred within the first 12 hours postopera-
tively, while the patient was in the nursing unit. It was
probably related to hemodynamic causes, because the
neurologic event was ipsilateral to the contralateral ca-
rotid occlusion and the endarterectomized vessel was
patent, with no technical defects, at postoperative an-
giography. Both patients underwent traditional CEA
with patching, with an average cross-clamping time of 20
minutes, with no EEG abnormalities and no need for
shunting.
p 2 (N  38) Group 3 (N  81)
P% n %
64.4
47-79
52.6 52 64.2 .02
47.4 64 79 .001
73.7 59 72.8 NS
18.4 38 46.9 .001
44.7 43 53.1 NS
13.1 8 9.9 NS
26.3 26 32.1 NS
23.7 50 61.7 .001
7.8 6 7.4 NS
rction; NS, not significant.
l data
up 2 (N  38) Group 3 (N  81)
P% n %
27
9
2
81
18.4 60 79 .001
15.7 43 53.1 .001
36.8† 31 38.3‡ NS
63.2† 50 61.7‡ NSGrou
n
3.9
0-93
0
8
8
7
7
5
0
9
3
ial infahnica
Gro
n
7
6
14
24
cant.
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(11%) perioperative TIAs were observed; most (13 of 19,
68.4%) occurred in the middle cerebral artery territory
ipsilateral to the contralateral carotid occlusion (Table III).
In all cases, duplex ultrasound scanning performed imme-
diately after the onset of neurologic symptoms showed
patency of the ICA operated on. Cerebral CT or MR
images in these patients were negative for any new ischemic
events. Overall, the difference between the groups was not
statistically significant.
When perioperative stroke and death rates were com-
bined with perioperative stroke and TIA rates to calculate
the overall incidence of these events for each group, there
was no statistically significant difference.
Perioperative clinical complications. Three patients
(1%) had perioperative congestive heart failure, including
two patients with a history of congestive heart failure.
Moreover, one of the patients with perioperative heart
failure also had a postoperative myocardial infarction. The
incidence of congestive heart failure or myocardial infarc-
tion did not statistically differ between the three groups
(Table III).
Minor complications. There were 11 (6.3%) neck
hematomas requiring surgical evacuation, with no further
complications; the suture line was intact in all cases, and
venous oozing was the only apparent source of bleeding.
The difference between the groups was not statistically
significant (Table III). There were also seven (4%) cranial
nerve dysfunctions, six temporary, resolving within 30 days,
and 1 persisting for more than 30 days. There was no
statistically significant difference between groups (Table
III).
None of the variables examined, that is, age 80 years or
older, gender, indication for surgery, preoperative risk fac-
Table III. End points and perioperative complications
End points and
complications
Group 1 (N  54) G
n % n
Stroke 0
Minor
Ipsilateral
Contralateral
Major
Ipsilateral
Contralateral
Death 0
Combined stroke
and death
0
TIA 9 16.6 2
Ipsilateral 2 3.7 2
Contralateral 7 12.9
Combined stroke
and TIA
9 16.6 2
MI 0
CHF 1 1.8 1
Neck hematoma 3 5.5 2
Nerve injury 2 3.7 2
TIA, Transient ischemic attack; MI, myocardial infarction; CHF, congestivtors, presence of contralateral carotid occlusion, type of
CEA, or need for shunting, were predictors of perioperative
stroke.
DISCUSSION
The lack of perioperative death and stroke in patients
with or without symptomatic disease, 80 years of age or
older with concomitant contralateral carotid occlusion,
demonstrates that CEA can be performed safely even in this
patient population. Our findings did not differ significantly
from observations in the two comparison groups: patients
younger than 80 years with contralateral carotid occlusion
and patients 80 years or older with patent contralateral
ICA. Moreover, these results represent an extension of two
previous studies reporting early and long-term outcome in
the elderly and in patients with contralateral carotid occlu-
sion.24,25 The lack of published studies reporting specifi-
cally on the results of CEA in a cohort with such character-
istics prevents us from drawing any useful comparisons.
However, our findings correlate well with those of numer-
ous other studies dealing with both CEA in the elderly 26-29
and CEA in patients with contralateral carotid occlu-
sion.30-33
The skepticism that has significantly curtailed the refer-
ral of elderly patients and patients with contralateral carotid
occlusion for CEA, prompting many of them to accept the
ambiguous option of CAS, appears unjustified. Although
there has been concern about the safety of CEA in elderly
patients, either because of their exclusion by randomization
procedures for large multicenter trials1-3 or because of their
higher risk for complications because of concomitant dis-
eases and limited life expectancy, numerous series have
failed to reveal any relationship between old age and peri-
operative mortality and strokes in the performance of CEA,
2 (N  38) Group 3 (N  81)
P% n %
0 2 2.5 .51
1
0
1
1
1
0
0 1 1.2 1
0 3 3.7 .27
5.2 8 9.9 NS
5.2 1 1.2 NS
0 6 8.7 .03
5.2 10 12.3 NS
0 1 1.2 NS
2.6 1 1.2 NS
5.2 6 8.7 NS
5.2 3 3.7 NS
failure; NS, not significant.roup
e heart
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strating that the very elderly could benefit from CEA more
than others.26-29 In contrast, in the largest experience
published by a single group of operators, with 604 CAS
procedures in 528 consecutive patients, 66 aged 80 years or
older, Roubin et al9 documented an alarming and unac-
ceptable 16% incidence of nonfatal stroke and death among
the elderly patients; thus one of the conclusions of the study
was that age 80 years or older was the best predictor of
30-day stroke and death. This finding is odd, but the
authors do not attempt to explain why CAS should result in
a significantly worse outcome in older patients than in
younger patients. If the elderly are truly a high-risk group,
one would expect the less invasive procedure to be toler-
ated better than CAS.
The effect of contralateral carotid occlusion on periop-
erative mortality and morbidity remains controversial. A
post hoc analysis from NASCET34 and a recently published
large population–based review from the Ontario Carotid
Endarterectomy Registry35 reported a significantly higher
incidence of perioperative adverse events in patients with
contralateral carotid occlusion. Conversely, a post hoc anal-
ysis from ACAS36 recorded much the same 30-day event
rate in the surgical arm in patients with and without con-
tralateral carotid occlusion (2.3% vs 2.2%), and a perusal of
the current literature revealed that excellent surgical results
in patients with and without symptoms with contralateral
carotid occlusion are by no means unique.30-33 Even
though all of these studies reported a slightly higher inci-
dence (lacking statistical significance) of perioperative
events in patients with contralateral carotid occlusion, we
believe it would be misleading to imply that the risk of
operating on patients with and without contralateral ca-
rotid occlusion is the same. Patients with contralateral
carotid occlusion may have collateral flow insufficient to
withstand the stress of clamping,36 which would explain the
higher incidence of perioperative EEG abnormalities re-
quiring shunting. Shunting did not appear to have a nega-
tive effect on perioperative outcome, however. The discrep-
ancy between the incidence of EEG changes and the need
to resort to shunting is explained exclusively by periproce-
dural technical reasons. Since eversion CEA is a rapid
surgical procedure (in our hands it takes on average 9
minutes [range, 5-18 minutes]), insertion of the shunt
becomes superfluous when the onset of EEG changes
consistent with cerebral ischemia is not immediate and the
procedure is nearly complete.22
The suggestion of the consensus statements that pa-
tients with contralateral carotid occlusion could be good
candidates for CAS procedures14,15 is consequently strik-
ing, because to date there have been no studies specifically
reporting the results of CAS in patients with contralateral
carotid occlusion. The rationale for preferring CAS over
CEA in patients with contralateral carotid occlusion ap-
pears to be based on two aspects that remain to be demon-
strated, that is, that CEA is a high-risk procedure and that
CAS is safer than CEA. Given the available data, CASshould not become accepted practice in patients with con-
tralateral carotid occlusion.
The present study has the inherent drawbacks of a
nonrandomized protocol; although data were collected
prospectively, the analysis was retrospective. Moreover,
although the report concerns the largest published group
of CEA procedures performed in patients 80 years or older
with concurrent contralateral carotid occlusion, the sample
size is still small, and the number of adverse events is zero;
thus the relative lack of power prevents any definitive
statistical analysis. The absence of perioperative stroke or
death in group 1 and in all patients 80 years or older,
together with the low incidence of major cerebrovascular
events in group 3, should be borne in mind when treating
carotid bifurcation disease in such patients. This study
would have benefited from a comparison of perioperative
death and stroke incidence with patients with contralateral
carotid occlusion of similar age who were followed up
without surgery. Because this study was retrospective, we
could not (nor did we intend to) analyze data for patients
who had indications for CEA but did not undergo surgery.
In conclusion, age 80 years or older and concomitant
contralateral carotid occlusion do not appear to increase the
perioperative incidence of death and stroke in CEA. While
awaiting the completion of prospective randomized trials
evaluating the role of CAS, CEA should remain the stan-
dard treatment even in such patients. Like many other
recently published surgical studies,16-20 the present series
provides further proof that the loose definitions of patients
at high risk used in the literature to justify extending CAS to
large numbers of patients outside of clinical trials are
flawed. We believe that if a high-risk subset of patients
exists, it is small and restricted to patients with severe or
symptomatic recurrent stenosis after previous CEA or with
radiation-induced stenosis.
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